Flumazenil
| Flumazenil | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 303.29 g/mol [1] |
| Melting point | 201-203 °C [1] |
| Solubility | 128 mg/L [1] |
| Predicted LogP | 1 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C15H14FN3O3 |
| IUPAC name | ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate |
| SMILES | CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C |
| InChI | InChI=1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3 |
| InChIKey | OFBIFZUFASYYRE-UHFFFAOYSA-N |
| CAS number | 78755-81-4 |
| UNII | 40P7XK9392 |
| PubChem CID | 3373 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 7–15 min (initial) , 20–30 min (brain) , 40–80 min (terminal) |
| Metabolism | Hepatic: hydrolysis of the ester and glucuronidation |
| Excretion | Urine 90–95% , Feces 5–10% |
| Routes of administration | Intranasal, intravenous |
Flumazenil (also known as Anexate, Flumazepil, Romazicon, Lanexat, Mazicon, Flumazenilo, Flumazenilum, Ro-15-1788, Ro 151788 or Ro-151788) is a substance of the benzylamine and benzodiazepine class.
Chemistry
Stereochemistry []
Flumazenil is achiral.
Druglikeness
Lipinski's rule of five
Flumazenil matches Lipinski's rule of five.Pharmacology
ATC Classification
- various (V)
- all other therapeutic products (V03)
- all other therapeutic products (V03A)
- antidotes (V03AB)
- flumazenil (V03AB25)
MeSH Classification
Mechanism of action []
Flumazenil, an imidazobenzodiazepine derivative, is a benzodiazepine antagonist. It competitively inhibits the benzodiazepine binding site on the GABA/benzodiazepine receptor complex. Flumazenil is a weak partial agonist in some animal models of activity, but has little or no agonist activity in man. [1]
Interactions []
Interaction mechanisms documented in KEGG DRUG (number of interacting drugs):
| GABRA1 | shared target | 54 |
|---|---|---|
| GABRA2 | shared target | 54 |
| GABRA3 | shared target | 54 |
| GABRA4 | shared target | 54 |
| GABRA5 | shared target | 54 |
| GABRA6 | shared target | 54 |
| GABRB1 | shared target | 54 |
| GABRB2 | shared target | 54 |
| GABRB3 | shared target | 54 |
| GABRD | shared target | 54 |
| GABRE | shared target | 54 |
| GABRG1 | shared target | 54 |
| GABRG2 | shared target | 54 |
| GABRG3 | shared target | 54 |
| GABRP | shared target | 54 |
| GABRQ | shared target | 54 |
Medical side effects []
98 side effects listed on drug labels in SIDER 4.1 (flumazenil).
- Vomiting
- Fear
- Panic disorder
- Panic attack
- Drug withdrawal syndrome
- Aggression
- Anger
- Anxiety
- Anxiety attack
- Arrhythmia
- Asphyxia
- Asthenia
- Fatigue
- Ataxia
- Chest pain
- Confusional state
- Feeling abnormal
- Malaise
- Cough
- Delirium
- Depersonalisation
- Diplopia
- Dizziness
- Somnolence
- Drug abuse
- Dyspnoea
- Epilepsy
- Dermatitis
- Rash
- Flushing
- Hallucination
- Headache
- Hiccups
- Hypersensitivity
- Hypertension
- Hyperventilation
- Hypoaesthesia
- Hypotension
- Nasal congestion
- Nausea
- Nervousness
- Tension
- Pain
- Palpitations
- Paraesthesia
- Pruritus
- Hyperacusis
- Salivary hypersecretion
- Scotoma
- Chills
- Rigors
- Congenital skin disorder
- Speech disorder
- Hyperhidrosis
- Sweating increased
- Tachycardia
- Supraventricular tachycardia
- Tetany
- Thrombophlebitis
- Tinnitus
- Tremor
- Urticaria
- Vasodilation procedure
- Ventricular tachycardia
- Vertigo
- Dry mouth
- Stupor
- Depressed level of consciousness
- Agitation
- Mood swings
- Affect lability
- Tongue disorder
- Tongue oedema
- Ventricular extrasystoles
- Injection site reaction
- Injection site pain
- Discomfort
- Ill-defined disorder
- Dysphoria
- Feeling cold
- Euphoric mood
- Hypopnoea
- Crying
- Tearfulness
- Erythema
- Vision blurred
- Depressed mood
- Bradycardia
- Dependence
- Menopausal symptoms
- Hot flush
- Insomnia
- Deafness
- Hearing impaired
- Psychotic disorder
- Paranoia
- Dysphonia
- Visual impairment
Indications
- Convulsion
- Hepatic impairment
- Panic disorder
- Renal clearances low
- Withdrawal symptom
Legal status []
- Australia: Flumazenil is a Schedule 4.
- Brazil: Flumazenil is a C1.[3]
- Canada: Flumazenil is Prescription only.
- United Kingdom: Flumazenil is Prescription only.
- United States: Flumazenil is Prescription only.
- Other: Flumazenil is a Rx-only.
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 3373, Flumazenil. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/3373
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Flumazenil. UNII: 40P7XK9392. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/40P7XK9392
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 18:02:27 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 18:02:23 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 18:02:23 |
| gsrs | ok | 2026-11-20 18:02:23 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0015336) | 2026-11-20 18:02:23 |
| kegg | ok | 2026-11-20 18:02:26 |
| pubchem | ok | 2026-11-20 18:02:23 |
| missing (no r/tripreports posts mention it) | 2026-11-20 18:02:23 | |
| sider | ok | 2026-11-20 18:02:23 |
| structure | ok | 2026-11-20 18:02:23 |
| wikipedia | ok | 2026-11-20 18:02:23 |